Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T16:12:49.046Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:12:49.046Z.

Quote observation: 2026-10-06T15:53:24.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 23,964,823
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 50,644,000
TTM operating EBITDA · period ending 2026-06-30: -50,621,000

FMP input reference: 0b8025f704655349782d47d219081ed0d317ba91c4dcab760c02f1a4064a70a5

EV/Sales|P/E Ratio|EBITDA|All Metrics

KYNB EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EV/EBITDA RATIO AVG TTM

N/A

EV/EBITDA RATIO AVG 3Y

N/A

EV/EBITDA RATIO AVG 5Y

N/A

EV/EBITDA RATIO AVG 10Y

N/A

EV/EBITDA RATIO AVG 15Y

N/A

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

KYNB Competitors' EV/EBITDA Ratio

KYNB

Kyntra Bio, Inc.

Current

Market Cap

$23.96M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATOS

Atossa Therapeutics, Inc.

vs KYNB

Market Cap

$24.74M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABVC

ABVC BioPharma, Inc.

vs KYNB

Market Cap

$24.96M

EV/EBITDA Ratio

N/A

TTM Avg

11456.84x

3Y Avg

11456.84x

5Y Avg

11456.84x

RNTX

Rein Therapeutics Inc.

vs KYNB

Market Cap

$22.75M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AYTU

Aytu BioPharma, Inc.

vs KYNB

Market Cap

$22.65M

EV/EBITDA Ratio

N/A

TTM Avg

6.88x

3Y Avg

5.95x

5Y Avg

5.95x

LONA

LeonaBio, Inc.

vs KYNB

Market Cap

$22.44M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ITOC

iTonic Holdings Ltd.

vs KYNB

Market Cap

$26.73M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NSPR

InspireMD, Inc.

vs KYNB

Market Cap

$26.27M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MODD

Modular Medical, Inc.

vs KYNB

Market Cap

$20.38M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QNTM

Quantum BioPharma Ltd.

vs KYNB

Market Cap

$20.54M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Kyntra Bio, Inc. (KYNB)	$23.96M	N/A	N/A	N/A	N/A
Atossa Therapeutics, Inc. (ATOS)vs ›	$24.74M	N/A	N/A	N/A	N/A
ABVC BioPharma, Inc. (ABVC)vs ›	$24.96M	N/A	11456.84x	11456.84x	11456.84x
Rein Therapeutics Inc. (RNTX)vs ›	$22.75M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.65M	N/A	6.88x	5.95x	5.95x
LeonaBio, Inc. (LONA)vs ›	$22.44M	N/A	N/A	N/A	N/A
iTonic Holdings Ltd. (ITOC)vs ›	$26.73M	N/A	N/A	N/A	N/A
InspireMD, Inc. (NSPR)vs ›	$26.27M	N/A	N/A	N/A	N/A
Modular Medical, Inc. (MODD)vs ›	$20.38M	N/A	N/A	N/A	N/A
Quantum BioPharma Ltd. (QNTM)vs ›	$20.54M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

KYNB EV/EBITDA Ratio History

DATE	EV/EBITDA RATIO
2020-03-02	73.20x
2020-02-28	70.82x
2020-02-27	68.63x
2020-02-26	70.23x
2020-02-25	72.86x
2020-02-24	73.97x
2020-02-21	77.30x
2020-02-20	77.02x
2020-02-19	77.69x
2020-02-18	76.14x
2020-02-14	77.48x
2020-02-13	75.59x
2020-02-12	77.09x
2020-02-11	75.81x
2020-02-10	73.90x
2020-02-07	73.41x
2020-02-06	77.50x
2020-02-05	78.15x
2020-02-04	77.85x
2020-02-03	73.58x
2020-01-31	70.90x
2020-01-30	71.66x
2020-01-29	71.24x
2020-01-28	71.04x
2020-01-27	70.48x
2020-01-24	70.82x
2020-01-23	74.98x
2020-01-22	74.18x
2020-01-21	72.83x
2020-01-17	75.31x
2020-01-16	75.74x
2020-01-15	72.01x
2020-01-14	72.54x
2020-01-13	70.78x
2020-01-10	71.26x
2020-01-09	72.07x
2020-01-08	72.60x
2020-01-07	72.35x
2020-01-06	73.55x
2020-01-03	73.09x
2020-01-02	74.45x
2019-12-31	72.74x
2019-12-30	73.65x
2019-12-27	76.26x
2019-12-26	79.53x
2019-12-24	77.94x
2019-12-23	76.32x
2019-12-20	76.99x
2019-12-19	79.00x
2019-12-18	78.66x
2019-12-17	80.85x
2019-12-16	80.76x
2019-12-13	79.44x
2019-12-12	81.11x
2019-12-11	80.51x
2019-12-10	81.85x
2019-12-09	81.32x
2019-12-06	80.67x
2019-12-05	80.23x
2019-12-04	79.60x
2019-12-03	75.12x
2019-12-02	74.69x
2019-11-29	71.82x
2019-11-27	68.75x
2019-11-26	67.68x
2019-11-25	68.22x
2019-11-22	64.89x
2019-11-21	63.89x
2019-11-20	63.75x
2019-11-19	63.50x
2019-11-18	62.12x
2019-11-15	62.33x
2019-11-14	58.79x
2019-11-13	58.09x
2019-11-12	58.71x
2019-11-11	58.44x
2019-11-08	68.77x
2019-11-07	62.71x
2019-11-06	63.29x
2019-11-05	66.03x
2019-11-04	61.11x
2019-11-01	66.11x
2019-10-31	64.67x
2019-10-30	64.77x
2019-10-29	64.95x
2019-10-28	67.26x
2019-10-25	65.46x
2019-10-24	66.06x
2019-10-23	64.13x
2019-10-22	65.43x
2019-10-21	64.82x
2019-10-18	64.08x
2019-10-17	66.92x
2019-10-16	66.57x
2019-10-15	64.18x
2019-10-14	62.81x
2019-10-11	61.58x
2019-10-10	60.52x
2019-10-09	60.40x
2019-10-08	60.02x
2019-10-07	60.91x
2019-10-04	60.70x
2019-10-03	59.82x
2019-10-02	58.36x
2019-10-01	59.87x
2019-09-30	61.06x
2019-09-27	62.43x
2019-09-26	62.37x
2019-09-25	63.09x
2019-09-24	62.87x
2019-09-23	67.47x
2019-09-20	65.91x
2019-09-19	65.50x
2019-09-18	67.67x
2019-09-17	68.42x
2019-09-16	69.10x
2019-09-13	68.55x
2019-09-12	70.31x
2019-09-11	71.77x
2019-09-10	68.23x
2019-09-09	66.97x
2019-09-06	68.87x
2019-09-05	69.50x
2019-09-04	68.58x
2019-09-03	68.83x
2019-08-30	73.81x
2019-08-29	75.70x
2019-08-28	74.89x
2019-08-27	72.28x
2019-08-26	74.04x
2019-08-23	68.93x
2019-08-22	71.94x
2019-08-21	74.16x
2019-08-20	73.73x
2019-08-19	75.07x
2019-08-16	73.71x
2019-08-15	71.29x
2019-08-14	71.64x
2019-08-13	74.52x
2019-08-12	74.61x
2019-08-09	76.37x

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics

EV/EBITDA Ratio: N/A

KYNB EV/EBITDA Ratio Chart

KYNB EV/EBITDA Ratio Metrics

KYNB Competitors' EV/EBITDA Ratio

EV/EBITDA Ratio Formula & Definition

KYNB EV/EBITDA Ratio History

Related Metrics